Barclays analyst Thomas O'Malley maintains $Micron Technology (MU.US)$ with a buy rating, and maintains the target price at $145.
According to TipRanks data, the analyst has a success rate of 52.2% and a total average return of 9.6% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Micron Technology (MU.US)$'s main analysts recently are as follows:
Micron delivered a robust quarter and outlook, particularly considering the dampened recent expectations, with EPS guidance aligning with consensus prior to the negative revisions. The company has met its sales goal in HBM for FY24, persisting in its projection to achieve several billion in sales next year and aiming to secure a mid-20s percentage in DRAM market share for HBM. However, there are concerns that the market forecast may be overly optimistic. Despite Micron's strong execution, concerns about the stock's valuation persist, suggesting there might be more favorable risk-reward opportunities in other AI and memory segments.
Micron's recent financial outcomes surpassed expectations, an achievement accentuated by prevailing macroeconomic challenges, driven by robust demand from data centers. This includes the company's advancement in AI-powered high-bandwidth memory sales. Despite anticipating a milder fiscal second quarter due to seasonal factors, projections for fiscal years 2025 and 2026 earnings per share have been notably increased.
Micron anticipates that its HBM share will align with its total DRAM market share by C2025, a key point underpinning the investment thesis for the stock, given the belief that HBM is capable of producing gross margins in the low-60% range and represents a 60% compound annual growth rate. It's still considered one of the top picks, with the valuation appearing attractive, and the market not fully accounting for the HBM opportunity.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
巴克莱银行分析师Thomas O'Malley维持$美光科技 (MU.US)$买入评级，维持目标价145美元。
根据TipRanks数据显示，该分析师近一年总胜率为52.2%，总平均回报率为9.6%。
此外，综合报道，$美光科技 (MU.US)$近期主要分析师观点如下：
美光公布了强劲的季度及前景，特别是考虑到近期预期疲软，在负面修正之前，每股收益指引与共识一致。该公司已实现其24财年hBm的销售目标，坚持其明年实现数十亿美元的销售额的预测，并旨在确保hbM在DRAM市场份额中达到20年代中期的百分比。但是，有人担心市场预测可能过于乐观。尽管美光表现强劲，但对该股估值的担忧仍然存在，这表明其他人工智能和存储器领域可能会有更有利的风险回报机会。
美光最近的财务业绩超出了预期，在数据中心强劲需求的推动下，当前的宏观经济挑战突显了这一成就。这包括该公司在人工智能驱动的高带宽内存销售方面的进展。尽管由于季节性因素，预计第二财季将温和，但对2025年和2026财年的每股收益的预测已显著增加。
美光预计，到 C2025，其 HbM 份额将与其 DraM 总市场份额持平，这是支撑该股投资论点的关键点，因为美光认为 hbM 能够在-60％的低范围内产生毛利率，复合年增长率为60％。它仍然被认为是首选之一，估值似乎很有吸引力，而且市场并未充分考虑HbM的机会。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
